Sara Tehrani

Sara Tehrani

Affiliated to Research
Visiting address: Entrévägen 2, 18257 Danderyd
Postal address: D1 Kliniska vetenskaper, Danderyds sjukhus, D1 Medicin Sepsis och mikrocirkulation, 171 77 Stockholm

About me

  • I am a clinical researcher with a focus on microvascular function and its role in health and disease. My research career began with a doctoral thesis, defended in 2014, which explored haemostatic alterations and microvascular dysfunction in patients with type 1 diabetes. In the subsequent postdoctoral phase, I investigated the association between circulating microvesicles and diabetic microangiopathy, further deepening the understanding of cellular mechanisms contributing to vascular complications.

     

    Currently, my research centers on the characterization and regulation of microvascular function across a range of clinical conditions. The overarching goal of my work is to improve the mechanistic understanding of microvascular dysfunction, identify potential biomarkers, and contribute to the development of more effective diagnostic and therapeutic strategies for vascular-related complications.

Research

  • My research focus is investigation and better understanding of microvascular regulation and dysfunction in various conditions. Microvascular dysfunction, characterized by impaired function of small blood vessels, is a critical factor in cardiovascular diseases, diabetes, and sepsis. However, current bedside assessment methods for microvascular dysfunction are limited, often requiring specialized equipment and expertise. Consequently, there is a critical need for innovative solutions that enable reliable assessment of microvascular function directly at the bedside and thereby facilitate early diagnosis and intervention.

     

    In my ongoing projects, we evaluate the use of point-of-care devices for bedside assessment of microvascular function in the skin, as cutaneous microcirculation serves as a suitable model for studying overall dynamics in microvascular function. The long-term goal of the research group is to develop a rapid and accurate method that enable early detection and targeted management of microvascular dysfunction in order to improve patient outcomes in both acute and chronic conditions that affect the microcirculation.

     

    The project includes three separate clinical studies:

    • MIND study, Microangiopathy in Diabetes, planning to include 300 patients with type 1 diabetes with or without clinical microangiopathy and 100 healthy controls.
    • SCAPIS spectrum, involving 900 research subjects with high or low risk of cardiovascular disease, including metabolic syndrome.
    • CapriS, Capillary function in Sepsis, involving 60 patients with severe sepsis and septic chock and 30 controls.

Teaching

  • Since 2018, I have been actively involved in teaching at Karolinska Institutet, giving lectures and supervising seminars for medical students. In addition, I have teached registrars and nurses undergoing specialty training with focus clinical reasoning and patient case discussions.

     

    I have served as the principal supervisor for one doctoral candidate and am currently supervising another as principal supervisor, in addition to co-supervising two other doctoral candidates. In my clinical role at the Intermediate Care Unit (IMCU) at Danderyd Hospital, I provide daily supervision and bedside teaching to medical students during their clinical rotations.

     

    I have also supervised four master’s thesis projects—three in medicine at Karolinska Institutet and one in computer science at the Royal Institute of Technology (KTH). 

Articles

All other publications

Grants

  • Impaired function in small blood vessels in acute and chronic disease conditions – development of an innovative method
    Region Stockholm
    1 January 2025 - 31 December 2026
  • Microvascular dysfunction in patients with sepsis and septic shock, evaluation of methods for beside monitoring in clinical practise.
    Region Stockholm
    1 January 2023 - 30 June 2026
  • Capillary function in Sepsis
    Swedish Society of Medicine
    5 June 2020 - 31 December 2020
  • Investigation of blood microparticles, a new approach to vascular complications in type 1 diabetes.
    Region Stockholm
    1 January 2018 - 31 December 2021

Employments

  • Associate consultant, Internal Medicine, Department of Medical Specialties, Danderyd Hospital, 2021-
  • Affiliated to Research, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2023-2026

Degrees and Education

  • Degree Of Doctor Of Philosophy, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2015
  • University Medical Degree, Karolinska Institutet, 2005

Leadership and responsibility assignments

  • Responsible for a section, Head of the Research, Education & Development, Department of Medical Specialties, Danderyds sjukhus, 2024-
  • Responsible for a section, Head of Clinical Research Laboratory at Danderyd Hospital, Danderyds sjukhus, 2021-

Supervision

  • Jacob Widaeus, Bedside assessment of microvascular dysfunction – method evaluation in clinical studies, 2024
  • Bergen Karin, Microvesicles, skin microcirculation and clinical microangiopathy in type 1 diabetes, 2016

News from KI

Events from KI